JHVEPhoto/iStock Editorial via Getty Images Pfizer ( PFE ) announced on Wednesday that Elrexfio, a treatment for a type of blood cancer called multiple myeloma, reached the primary endpoint in a late-stage trial, raising prospects for the immunotherapy, which is already available in the U.S. under the FDA’s accelerated pathway. Citing topline data, the company stated that its Phase 3 MagnetisMM-5 ...
JHVEPhoto/iStock Editorial via Getty Images Pfizer ( PFE ) announced on Wednesday that Elrexfio, a treatment for a type of blood cancer called multiple myeloma, reached the primary endpoint in a late-stage trial, raising prospects for the immunotherapy, which is already available in the U.S. under the FDA’s accelerated pathway. Citing topline data, the company stated that its Phase 3 MagnetisMM-5 study met the main goal, as patients who received Elrexfio survived longer without cancer (progression‑free survival) with a statistically significant and clinically meaningful effect. The injectable, which was granted the FDA's accelerated approval in 2023 as a late-line option for RRMM, indicated a safety and tolerability profile in line with its established safety profile, Pfizer ( PFE ) added. The open-label study was designed to evaluate Elrexfio as a single agent versus standard of care in nearly 500 adults with relapsed or refractory MM who had already received one or more prior lines of therapy. While the trial is set to continue to assess overall survival, a key secondary endpoint, Pfizer ( PFE ) plans to share the existing results with global regulators. More on Pfizer Pfizer Could Surprise Again This Earnings Season (Preview) Pfizer: Painful Recovery Underway Pfizer: Why Wall Street Habitually Overestimates Target Price BridgeBio seesaws after settlement in Pfizer Vyndamax patent dispute (update) BridgeBio gains amid report of settlement in Pfizer Vyndamax patent dispute
George Frey/Getty Images News Generac ( GNRC ) up 14.5% in Wednesday's trading to $255.87, its highest intraday level in more than three and a half years, after easily beating Q1 adjusted earnings expectations, lifted by solid demand for backup generators and a growing backlog from data center customers, and raising full-year guidance. Q1 profit rose to $73M, or $1.24/share, from $44M, or $0.73/...
George Frey/Getty Images News Generac ( GNRC ) up 14.5% in Wednesday's trading to $255.87, its highest intraday level in more than three and a half years, after easily beating Q1 adjusted earnings expectations, lifted by solid demand for backup generators and a growing backlog from data center customers, and raising full-year guidance. Q1 profit rose to $73M, or $1.24/share, from $44M, or $0.73/share, in the year-earlier quarter, and revenue rose 12.5% Y/Y to $1.06B, as sales in the residential segment edged up 1% Y/Y to $549M and sales in the commercial and industrial segment jumped 28% to $510M. Generac ( GNRC ) said it now sees FY 2026 revenue growth in the mid-to-high teens percent range, which translates to a range of $4.84B-$5B, compared to the $4.85B FactSet consensus estimate and up from the company's prior forecast of the mid-teens range, and boosts guidance for adjusted EBITDA margin to 18.5%-19.5% from its prior outlook of 18%-19%. Generac ( GNRC ) "reported 1Q revenue slightly above expectations, primarily driven by the C&I business," according to J.P. Morgan analyst Mark Strouse, who rates the stock at Overweight. "Gross margin was particularly strong, driven by price-cost realization, and resulting in a solid EPS beat." "We are continuing to build momentum in the large and rapidly growing data center end market as we are in the final stages of vendor approval with multiple hyperscale customers and have expanded our backlog for these products with both new and existing customers," President and CEO Aaron Jagdfeld said. More on Generac Generac: Strong C&I Momentum, But Residential Risk Remains Generac: Shares Power To 52-Week Highs After A Ho-Hum Q4 Generac Analyst/Investor Day - Slideshow
Third Avenue Real Estate Value Fund generated a return of -10.02% for the first quarter, underperforming its benchmark, the MSCI ACWI IMI Core Real Estate Index, which returned +0.59%. The primary contributors to performance during the period included the fund's industrial real estate and logistics holdings, such as Prologis ( PLD ), WESCO International ( WCC ), and First Industrial ( FR ), as wel...
Third Avenue Real Estate Value Fund generated a return of -10.02% for the first quarter, underperforming its benchmark, the MSCI ACWI IMI Core Real Estate Index, which returned +0.59%. The primary contributors to performance during the period included the fund's industrial real estate and logistics holdings, such as Prologis ( PLD ), WESCO International ( WCC ), and First Industrial ( FR ), as well as certain Asian-based investments, including CK Asset Holdings ( CHKGF ) and Jardine Matheson Holdings ( JMHLY ). However, these gains were more than offset by detractors during the quarter, including the Fund's investments in real estate services companies such as CBRE Group ( CBRE ), JLL ( JLL ), and Savills (SVLNF); residential-related businesses like Lennar ( LEN ) and the preferred equity of Fannie Mae ( FNMA ) and Freddie Mac; and U.K.-based property companies Big Yellow ( BYLOF ) plc and Berkeley Group ( BKGFY ). During the quarter, the Fund invested in Brookdale Senior Living ( BKD ) and Hang Lung Group ( HNLGY ). According to its quarterly fund letter, the fund added to several holdings where the price-to-value gap broadened to historically wide levels amid recent volatility, including certain commercial-centric issuers such as U-Haul Holdings ( UHAL ) and FirstService Corp. ( FSV ), as well as select international companies, including Accor SA ( ACCYY ) and Ingenia Communities (INGAF). On the other hand, the Fund also trimmed its position in CK Asset Holdings, exited several positions following corporate activity, including National Storage REIT ( NTSGF ), F&G Annuities ( FG ), Rayonier ( RYN ), and Unite Group, and extended the Fund's Hong Kong Dollar hedge. Source: Q1 2026 shareholder letter More on Brookdale Senior Living, Hang Lung Group, etc. Hang Lung Group: International Shifts Seem Constructive For Investment Brookdale Senior Living: A Compelling Backdrop F&G Annuities & Life: Addressing Market Fears Over Its Private Credit Exposure Brookdale March occu...
The market’s latest artificial intelligence panic says more about investor psychology than it does about the future of AI. Reports that OpenAI missed some of its internal growth targets helped trigger a sharp selloff across semiconductor and AI infrastructure stocks yesterday, though many names recovered some of the lost ground. Investors suddenly started treating the ... Semiconductor Stocks Tumb...
The market’s latest artificial intelligence panic says more about investor psychology than it does about the future of AI. Reports that OpenAI missed some of its internal growth targets helped trigger a sharp selloff across semiconductor and AI infrastructure stocks yesterday, though many names recovered some of the lost ground. Investors suddenly started treating the ... Semiconductor Stocks Tumble on OpenAI Warning. Google Says The Market Has It All Wrong
Image source: The Motley Fool. April 29, 2026, at 8 a.m. ET SoFi Technologies (NASDAQ:SOFI) reported a record-setting quarter, marked by all-time highs in member and product additions, and adjusted net revenue exceeding $1 billion, all underpinned by accelerating growth in lending and non-lending segments. Management announced the rebranding of its technology platform business to SoFi Technology S...
Image source: The Motley Fool. April 29, 2026, at 8 a.m. ET SoFi Technologies (NASDAQ:SOFI) reported a record-setting quarter, marked by all-time highs in member and product additions, and adjusted net revenue exceeding $1 billion, all underpinned by accelerating growth in lending and non-lending segments. Management announced the rebranding of its technology platform business to SoFi Technology Solutions and highlighted the strategic launch and minting of SoFiUSD stablecoin, securing partnerships such as with Mastercard for round-the-clock settlement infrastructure. Guidance anticipates continued top-line and margin expansion across all business lines, despite expected elevated marketing and innovation investment impacting near-term margins. Capital markets activity remained active, with $3.8 billion of loans sold or transferred and the company recording best-in-class securitization costs, supporting high capital ratios and flexible balance sheet management. Continue reading
I keep buying Palantir (NASDAQ:PLTR), and the 20.57% drawdown year to date has only made my finger heavier on the buy button. This is the confession part: I am accumulating a stake in the one software company I believe is turning generative AI into operating leverage at industrial scale, and every pullback in 2026 has ... Why I Keep Pressing the Buy Button on Palantir’s $4.38B Deal Pipeline
I keep buying Palantir (NASDAQ:PLTR), and the 20.57% drawdown year to date has only made my finger heavier on the buy button. This is the confession part: I am accumulating a stake in the one software company I believe is turning generative AI into operating leverage at industrial scale, and every pullback in 2026 has ... Why I Keep Pressing the Buy Button on Palantir’s $4.38B Deal Pipeline
Key PointsState Street SPDR S&P 600 Small Cap Value ETF focuses on smaller stocks while iShares S&P Mid-Cap 400 Value ETF targets the mid-cap market segment.
Key PointsState Street SPDR S&P 600 Small Cap Value ETF focuses on smaller stocks while iShares S&P Mid-Cap 400 Value ETF targets the mid-cap market segment.
European banks are being more selective on asset-backed lending, as collapses including Tricolor Holdings and Market Financial Solutions Ltd. have made firms more cautious of the sector. BNP Paribas SA , Deutsche Bank AG and Banco Santander SA are among banks that are being more particular about which deals they participate in, according to people with knowledge of the matter. It’s become more dif...
European banks are being more selective on asset-backed lending, as collapses including Tricolor Holdings and Market Financial Solutions Ltd. have made firms more cautious of the sector. BNP Paribas SA , Deutsche Bank AG and Banco Santander SA are among banks that are being more particular about which deals they participate in, according to people with knowledge of the matter. It’s become more difficult to get deals accepted through risk committees, especially for loans to smaller borrowers, said the people, who asked not to be identified discussing private information. Companies that tap asset-backed loans are often specialty lenders or firms with large inventories that can be used as collateral. The former typically use such borrowings to fund their own lending operations. Banks are doing more to scrutinize credit quality and ensure risk is priced appropriately. That’s making it more difficult for smaller borrowers that rely on asset-backed loans to obtain funding, the people said. Spokespeople for BNP and Deutsche Bank declined to comment. A spokesperson for Santander didn’t provide a comment. In recent years, banks have ramped up asset-backed lending to reap the benefits of higher-paying loans. Such deals also come with the protection of collateral that either bears income or can be sold in the event of default. However, the industry has come under scrutiny since the collapses of subprime auto lender Tricolor, UK mortgage lender Market Financial Solutions, known as MFS, and US auto parts firm First Brands Group , which all had some sort of asset-backed financing. Banks that weren’t exposed to the blow-ups want to ensure they don’t end up in such scenarios. “Across the market, participants are ramping up their due diligence processes, even among the most established players,” said Michele Bisceglia, chief executive of Five Sigma Finance, which conducts due diligence on asset-backed deals. Executives from Five Sigma and others including Interpath and Kroll said th...
Handcrafted e-commerce platform Etsy (NYSE: ETSY) hasn't given shareholders too many reasons to cheer over the past few years. It's off an astounding 79% from its all-time highs as it has failed to regain traction after a pandemic-fueled surge. But it's been making some changes, and the stock has gained 37% over the past year. Believe it or not, a long-term growth scenario is still on the table. H...
Handcrafted e-commerce platform Etsy (NYSE: ETSY) hasn't given shareholders too many reasons to cheer over the past few years. It's off an astounding 79% from its all-time highs as it has failed to regain traction after a pandemic-fueled surge. But it's been making some changes, and the stock has gained 37% over the past year. Believe it or not, a long-term growth scenario is still on the table. Here's how it could happen. Etsy was more of a niche company before COVID, when people were delighted with custom-designed face masks, sales exploded, and it became a household name. Continue reading
US Sanctions 35 Individuals, Entities To Dismantle Iran's Shadow Banking Authored by Kimberly Hayek via The Epoch Times (emphasis ours), The U.S. Treasury Department on April 28 imposed sanctions on 35 individuals and entities accused of running Iran’s secret shadow banking network. US Treasury Secretary Scott Bessent speaks during a press briefing in the Brady Briefing Room at the White House in ...
US Sanctions 35 Individuals, Entities To Dismantle Iran's Shadow Banking Authored by Kimberly Hayek via The Epoch Times (emphasis ours), The U.S. Treasury Department on April 28 imposed sanctions on 35 individuals and entities accused of running Iran’s secret shadow banking network. US Treasury Secretary Scott Bessent speaks during a press briefing in the Brady Briefing Room at the White House in Washington, on April 15, 2026. Brendan Smialowski/AFP via Getty Images Treasury has accused the network of transferring tens of billions of dollars to help Iran dodge U.S. sanctions and finance terrorism. The Department of the Treasury’s Office of Foreign Assets Control is sanctioning a network of shell companies, exchange houses, and operators connected to Iranian banks, such as Shahr Bank, that have enabled the Islamic Revolutionary Guard Corps (IRGC) and other Iran-backed armed forces to gain access to the international financial system. U.S. officials said the networks facilitate payments for illicit Iranian oil sales, purchases of missile components, and transfers to Tehran’s terrorist proxies. “Iran’s shadow banking system serves as a critical financial lifeline for its armed forces, enabling activities that disrupt global trade and fuel violence across the Middle East,” Secretary of the Treasury Scott Bessent said in a statement. “ Illicit funds funneled through this network support the regime’s ongoing terrorist operations, posing a direct threat to U.S. personnel, regional allies, and the global economy. Financial institutions are on notice: Any institution that facilitates or engages with these networks is at risk of severe consequences.” Those targeted on Tuesday include the Farab Soroush Afagh Qeshm Company, described as overseeing fund movements for Shahr Bank’s clients through foreign front companies. Sorayya Mehri Hajibaba, an employee and foreign exchange expert, was sanctioned for facilitating transfers since at least mid-2023. And Seyyed Mohammed Mehdi Al ...
The Deluxe edition of Elden Ring Nightreign comes with DLC and is on sale. | Image: Bandai Namco Amazon’s annual Gaming Week is bringing discounts on video games, accessories, and PC components through May 4th. This event is smaller than Amazon’s other sales, but there are some genuinely good deals. This year, we’ve found deals on popular titles like Elden Ring Nightreign , plus rare discounts on ...
The Deluxe edition of Elden Ring Nightreign comes with DLC and is on sale. | Image: Bandai Namco Amazon’s annual Gaming Week is bringing discounts on video games, accessories, and PC components through May 4th. This event is smaller than Amazon’s other sales, but there are some genuinely good deals. This year, we’ve found deals on popular titles like Elden Ring Nightreign , plus rare discounts on the Nex Playground console and on top-notch Nintendo Switch 2 controllers like the EasySMX S10 . We’ve also found discounts on an assortment of laptops , monitors , and other gaming gear , some of which are happening at Amazon and other retailers, too. Nex Playground The Nex Playground is a motion-controlled console that uses its built-in camera to track your movements as you play on the TV. Designed for ages five and up, it comes with games like Fruit Ninja and Whack-a-Mole Deluxe . You can download more games, including titles featuring popular characters like Elmo, with a paid Play Pass subscription. Where to Buy: $299 $239 at Amazon $299 $239 at Best Buy $299 $239 at Walmart You can buy the AMD Ryzen 7 7800X3D processor for $324.99 ($125 off) at Amazon , which is its second-best price to date. The impressive eight-core processor can handle multitasking without slowing down, with fast clock speeds, surprising efficiency when under pressure, and a lot of cache memory compared to other models at this price point. AMD’s 3D V-Cache specializes in helping games run smoother and possibly faster, depending on the capabilities of your other components. Read our review. Razer’s Basilisk V3 Pro wireless gaming mouse is on sale for $129.99 ($30 off), its second-best price, at Amazon and Best Buy . The accessory features a 35K DPI optical sensor, which lets gamers achieve more precise aim no matter their sensitivity preferences. It offers 13 programmable buttons, while Razer’s HyperScroll tilt wheel lets you lets you choose between controlled scrolling and quicker, free-spin scrolli...
cbarnesphotography/iStock via Getty Images Health Canada on Tuesday approved a generic version of Novo Nordisk's blockbuster GLP-1 semaglutide injection, which is branded as Ozempic for type 2 diabetes. The approval was granted to India-based Dr. Reddy's Laboratories. The authorization does not apply to semaglutide's use for weight loss, which is marketed as Wegovy. Health Canada noted that eight ...
cbarnesphotography/iStock via Getty Images Health Canada on Tuesday approved a generic version of Novo Nordisk's blockbuster GLP-1 semaglutide injection, which is branded as Ozempic for type 2 diabetes. The approval was granted to India-based Dr. Reddy's Laboratories. The authorization does not apply to semaglutide's use for weight loss, which is marketed as Wegovy. Health Canada noted that eight other applications for generic semaglutide are pending review. They include Teva Canada ( TEVA ), Sandoz Canada ( SDZNY )( SDZXF ), Apotex, and Taro Pharmaceuticals. Canada is now the first G7 country to approve a semaglutide generic. More on Novo Nordisk A/S Novo Nordisk: Is The GLP‑1 Golden Age Already Behind It? Novo Nordisk's Weight Loss Doesn't Mean To Load Up Novo Nordisk: Intense Competition Within The GLP-1 Duopoly Novo’s Wegovy expands reach in UK with latest NICE recommendation Novo’s China obesity drug posts positive mid-stage trial results